Basic & Clinical Medicine ›› 2015, Vol. 35 ›› Issue (3): 417-420.

Previous Articles     Next Articles

Advances in the research of targeting the signaling pathways of leukaemia stem cells in chronic myeloid leukaemia

  

  • Received:2014-05-26 Revised:2014-09-27 Online:2015-03-05 Published:2015-03-03

Abstract: Leukaemia stem cells (LSCs) is the main source of drug resistance, recur- rence and poor prognosis in treatment of chronic myeloid leukemia (CML). Specific elimination of LSCs is expected to become a way to cure CML. The signaling path-ways in LSCs are abnormal, such as WNT/β –catenin,JAK/STAT,PI3K/AKT, and so on.

Key words: chronic myeloid leukaemia, leukaemia stem cells, signaling pathway

CLC Number: